CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy.
Lanuti P PhD, Guardalupi F, Corradi G PhD, Florio R PhD, Brocco D MD, PhD, Veschi S PhD, Pennese E MD, De Bellis D PhD student, D'Ascanio F PhD Student, Piro A PhD Student, De Lellis L PhD, Simeone P, Cufaro MC, Pilato S PhD, D'Amario I PhD student, Villanova I PhD, Di Francesco B PhD, Di Re L PhD Student, Verginelli F PhD, Pieragostino D, Salutari P MD, Colasante F MD, Natale A MD, Mattoli MV MD, Vespa S, Fontana A PhD, Giancola R MD, PhD, Fabi B MD, Baldoni S, Santarone S, Restuccia F, Tinari N MD, PhD, Del Boccio P, Cama A PhD, MD, Di Ianni M.
Lanuti P PhD, et al. Among authors: veschi s phd.
Blood Adv. 2025 Feb 4:bloodadvances.2024014860. doi: 10.1182/bloodadvances.2024014860. Online ahead of print.
Blood Adv. 2025.
PMID: 39903124